• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奎尼丁作为一种用于测试血脑屏障处药物相互作用的ABCB1探针:一项体外-体内相关性研究。

Quinidine as an ABCB1 probe for testing drug interactions at the blood-brain barrier: an in vitro in vivo correlation study.

作者信息

Sziráki István, Erdo Franciska, Beéry Erzsébet, Molnár Petra Magdolna, Fazakas Csilla, Wilhelm Imola, Makai Ildikó, Kis Emese, Herédi-Szabó Krisztina, Abonyi Tibor, Krizbai István, Tóth Gábor K, Krajcsi Péter

机构信息

Laboratory of Microdialysis, Solvo Biotechnology, Berlini u. 47-49, Budapest, Hungary.

出版信息

J Biomol Screen. 2011 Sep;16(8):886-94. doi: 10.1177/1087057111414896. Epub 2011 Aug 10.

DOI:10.1177/1087057111414896
PMID:21832259
Abstract

This study provides evidence that quinidine can be used as a probe substrate for ABCB1 in multiple experimental systems both in vitro and in vivo relevant to the blood-brain barrier (BBB). The combination of quinidine and PSC-833 (valspodar) is an effective tool to assess investigational drugs for interactions on ABCB1. Effects of quinidine and substrate-inhibitor interactions were tested in a membrane assay and in monolayer assays. The authors compared quinidine and digoxin as ABCB1 probes in the in vitro assays and found that quinidine was more potent and at least as specific as digoxin in ATPase and monolayer efflux assays employing MDCKII-MDR1 and the rat brain microcapillary endothelial cell system. Brain exposure to quinidine was tested in dual-/triple-probe microdialysis experiments in rats by assessing levels of quinidine in blood and brain. Comparing quinidine levels in dialysate samples from valspodar-treated and control animals, it is evident that systemic/local administration of the inhibitor diminishes the pumping function of ABCB1 at the BBB, resulting in an increased brain penetration of quinidine. In sum, quinidine is a good probe to study ABCB1 function at the BBB. Moreover, quinidine/PSC-833 is an ABCB1-specific substrate/inhibitor combination applicable to many assay systems both in vitro and in vivo.

摘要

本研究提供了证据表明,在与血脑屏障(BBB)相关的多个体外和体内实验系统中,奎尼丁可作为ABCB1的探针底物。奎尼丁与PSC-833(伐司朴达)的组合是评估研究药物与ABCB1相互作用的有效工具。在膜试验和单层试验中测试了奎尼丁和底物-抑制剂相互作用的影响。作者在体外试验中比较了奎尼丁和地高辛作为ABCB1探针,发现在使用MDCKII-MDR1和大鼠脑微血管内皮细胞系统的ATP酶和单层外排试验中,奎尼丁比地高辛更有效且至少具有相同的特异性。通过评估血液和脑中奎尼丁的水平,在大鼠的双/三探针微透析实验中测试了脑对奎尼丁的暴露情况。比较来自伐司朴达处理动物和对照动物的透析液样本中的奎尼丁水平,很明显,抑制剂的全身/局部给药会降低BBB处ABCB1的泵功能,导致奎尼丁的脑渗透增加。总之,奎尼丁是研究BBB处ABCB1功能的良好探针。此外,奎尼丁/PSC-833是一种ABCB1特异性底物/抑制剂组合,适用于许多体外和体内试验系统。

相似文献

1
Quinidine as an ABCB1 probe for testing drug interactions at the blood-brain barrier: an in vitro in vivo correlation study.奎尼丁作为一种用于测试血脑屏障处药物相互作用的ABCB1探针:一项体外-体内相关性研究。
J Biomol Screen. 2011 Sep;16(8):886-94. doi: 10.1177/1087057111414896. Epub 2011 Aug 10.
2
The use of microdialysis techniques in mice to study P-gp function at the blood-brain barrier.在小鼠中使用微透析技术研究血脑屏障处P-糖蛋白的功能。
J Biomol Screen. 2013 Apr;18(4):430-40. doi: 10.1177/1087057112468156. Epub 2012 Nov 29.
3
Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.依非韦伦在血脑屏障处不与ABCB1转运蛋白相互作用。
Pharm Res. 2006 Jul;23(7):1525-32. doi: 10.1007/s11095-006-0279-5. Epub 2006 Jun 21.
4
A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.一种在啮齿动物中使用艾拉司群的简化方案:药物发现中用于评估血脑屏障处P-糖蛋白介导的外排的筛选模型。
Drug Metab Lett. 2012 Jun 1;6(2):134-44.
5
In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study.在体诱导小鼠血脑屏障 P-糖蛋白表达:脑室内微透析研究。
J Neurochem. 2013 Nov;127(3):342-52. doi: 10.1111/jnc.12344. Epub 2013 Jul 15.
6
Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats.P-糖蛋白对血视网膜屏障通透性的影响:利用 mdr1a 基因敲除大鼠比较血-房水和血-脑屏障。
Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819.
7
Modulation of nose-to-brain delivery of a P-glycoprotein (MDR1) substrate model drug (quinidine) in rats.大鼠中P-糖蛋白(MDR1)底物模型药物(奎尼丁)鼻脑给药的调控
Brain Res Bull. 2020 Jul;160:65-73. doi: 10.1016/j.brainresbull.2020.04.012. Epub 2020 Apr 26.
8
Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.血脑屏障模型:中枢神经系统靶向生物治疗药物临床前开发中从体外到体内的转化
Expert Opin Drug Discov. 2015 Feb;10(2):141-55. doi: 10.1517/17460441.2015.974545. Epub 2014 Nov 12.
9
Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain.血小板激活因子诱导短暂的血脑屏障开放,促进依达拉奉渗透入脑。
J Neurochem. 2014 Mar;128(5):662-71. doi: 10.1111/jnc.12507. Epub 2013 Nov 14.
10
Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.开发一种人源化体外血脑屏障模型以筛选抗癫痫药物的脑渗透性。
Epilepsia. 2007 Mar;48(3):505-16. doi: 10.1111/j.1528-1167.2006.00960.x. Epub 2007 Feb 22.

引用本文的文献

1
Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction.过表达MDR1的Abcb1基因敲除MDCKII细胞系在研究体外种属差异和脑穿透预测中的适用性
Pharmaceutics. 2024 May 29;16(6):736. doi: 10.3390/pharmaceutics16060736.
2
Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers.利用共聚焦拉曼光谱和微流控扩散室对切除皮肤和人重建表皮进行结构与功能分析
Pharmaceutics. 2022 Aug 13;14(8):1689. doi: 10.3390/pharmaceutics14081689.
3
Age-Related Inflammatory Balance Shift, Nasal Barrier Function, and Cerebro-Morphological Status in Healthy and Diseased Rodents.
健康和患病啮齿动物的年龄相关炎症平衡转移、鼻屏障功能和脑形态学状态
Front Neurosci. 2021 Jul 23;15:700729. doi: 10.3389/fnins.2021.700729. eCollection 2021.
4
Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?血脑屏障处活性药物外排的新型内在机制:增强药物脑内递送的潜在靶点?
Pharmaceutics. 2020 Oct 14;12(10):966. doi: 10.3390/pharmaceutics12100966.
5
Verification of P-Glycoprotein Function at the Dermal Barrier in Diffusion Cells and Dynamic "Skin-On-A-Chip" Microfluidic Device.在扩散池和动态“芯片上皮肤”微流控装置中对皮肤屏障处P-糖蛋白功能的验证
Pharmaceutics. 2020 Aug 25;12(9):804. doi: 10.3390/pharmaceutics12090804.
6
Prediction of Drug Permeability Using Blood-Brain Barrier Models with Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells.利用人诱导多能干细胞衍生的脑微血管内皮细胞构建血脑屏障模型预测药物渗透性
Biores Open Access. 2019 Nov 14;8(1):200-209. doi: 10.1089/biores.2019.0026. eCollection 2019.
7
Age-Related Functional and Expressional Changes in Efflux Pathways at the Blood-Brain Barrier.血脑屏障处外排途径的年龄相关功能和表达变化
Front Aging Neurosci. 2019 Jul 30;11:196. doi: 10.3389/fnagi.2019.00196. eCollection 2019.
8
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.两名婴儿癫痫伴局灶性阵挛发作(EIMFS)因 KCNT1 功能获得性突变所致,早期应用奎尼丁治疗:功能研究、临床反应及个体化治疗的关键问题。
Neurotherapeutics. 2018 Oct;15(4):1112-1126. doi: 10.1007/s13311-018-0657-9.
9
Membrane Assays to Characterize Interaction of Drugs with ABCB1.用于表征药物与ABCB1相互作用的膜分析
J Membr Biol. 2015 Dec;248(6):967-77. doi: 10.1007/s00232-015-9804-y. Epub 2015 Apr 30.
10
PACAP enhances barrier properties of cerebral microvessels.垂体腺苷酸环化酶激活肽增强脑微血管的屏障特性。
J Mol Neurosci. 2014 Nov;54(3):469-76. doi: 10.1007/s12031-014-0260-4. Epub 2014 Mar 11.